Cargando…

Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Detalles Bibliográficos
Autores principales:	Trøseid, Marius, Hentzien, Maxime, Ader, Florence, Cardoso, Sandra Wagner, Arribas, Jose R., Molina, Jean-Michel, Mueller, Nicolas, Hites, Maya, Bonnet, Fabrice, Manuel, Oriol, Costagliola, Dominique, Grinsztejn, Beatriz, Olsen, Inge Christoffer, Yazdapanah, Yazdan, Calmy, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130310/ https://www.ncbi.nlm.nih.gov/pubmed/35623577 http://dx.doi.org/10.1016/j.cmi.2022.05.005

Ejemplares similares

Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021)

A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab
por: Hentzien, Maxime, et al.
Publicado: (2022)

What progress has been made in treatment of immunocompromised COVID-19 patients?
por: Ader, F., et al.
Publicado: (2022)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
por: Trøseid, Marius, et al.
Publicado: (2022)

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
por: Hentzien, Maxime, et al.
Publicado: (2022)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
por: Diallo, Alpha, et al.
Publicado: (2022)

Analysis validation has been neglected in the Age of Reproducibility
por: Lotterhos, Kathleen E., et al.
Publicado: (2018)

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
por: Ader, Florence, et al.
Publicado: (2022)

Do not call it COVID-19, it might have been the second wave
por: Rühli, Frank, et al.
Publicado: (2020)

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
por: Ader, Florence, et al.
Publicado: (2022)

Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman® array card
por: Steensels, Deborah, et al.
Publicado: (2019)

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection
por: Trøseid, Marius, et al.
Publicado: (2023)

Minireview on Novel Anti-infectious Treatment Options and Optimized Drug Regimens for Sepsis
por: Hites, Maya
Publicado: (2021)

A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
por: Bonanni, Paolo, et al.
Publicado: (2023)

Neglecting the call of the wild: Captive frogs like the sound of their own voice
por: Passos, Luiza Figueiredo, et al.
Publicado: (2017)

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Amstutz, Alain, et al.
Publicado: (2023)

Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
por: Mercier, Noémie, et al.
Publicado: (2023)

Communication in Neglected Tropical Diseases’ elimination: A scoping review and call for action
por: Nieto-Sanchez, Claudia, et al.
Publicado: (2022)

Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better
por: Hites, Maya, et al.
Publicado: (2022)

Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians.
por: Grant, S, et al.
Publicado: (1999)

“They have been neglected for a long time”: a qualitative study on the role and recognition of rural health motivators in the Shiselweni region, Eswatini
por: Walker, Caroline, et al.
Publicado: (2020)

A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient
por: Hogan, John I, et al.
Publicado: (2021)

Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action
por: Franc, K. A., et al.
Publicado: (2018)

Fungal diseases as neglected pathogens: A wake-up call to public health officials
por: Rodrigues, Marcio L., et al.
Publicado: (2020)

COVID-19’s impact on neglected pharmaceutical staff: wake-up call for needed research
por: Powell, Richard Antony, et al.
Publicado: (2021)

Long‐COVID in people with intellectual disabilities: A call for research of a neglected area
por: Rawlings, Gregg H., et al.
Publicado: (2022)

World Neglected Tropical Diseases Day: WHO calls for equitable health services for all
Publicado: (2022)

World Neglected Tropical Diseases Day: WHO calls for equitable health services for all
Publicado: (2022)

Which adults in the Paris metropolitan area have never been tested for HIV? A 2010 multilevel, cross-sectional, population-based study
por: Massari, Véronique, et al.
Publicado: (2015)

How to Use Nebulized Antibiotics in Severe Respiratory Infections
por: Gorham, Julie, et al.
Publicado: (2023)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
por: Gorham, Julie, et al.
Publicado: (2023)

The Progress of Our School: Has It Been What It Should Have Been? If Not, Why Not?
por: Adams, Edward
Publicado: (1899)

Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic
por: Brüssow, Harald, et al.
Publicado: (2021)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

Neglected tropical diseases and the sustainable development goals: an urgent call for action from the front line
por: Addisu, Ayenew, et al.
Publicado: (2019)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review
por: Gorham, Julie, et al.
Publicado: (2022)

Advocacy for identifying certain animal diseases as “neglected”
por: Roger, François Louis, et al.
Publicado: (2017)

Rewriting Evolution—“Been There, Done That”
por: Penny, David
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_56r68g30j4lilv4f3j302ge6p1